drugset / Trial / NCT02985216
Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic Pain
RandomizedParallel-groupDouble-blindTreatment
Summary
A Randomized, Double-blind, Active-Controlled, Multi-center, Phase 3 Trial to Compare the Safety and Efficacy between YHD1119 and Pregabalin in Patients with Peripheral Neuropathic Pain
Timeline
- Start
- 2017-02-07
- Primary completion
- 2018-04-27
- Completion
- 2018-05-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pregabalin | Small molecule | 75 mg | Oral |
| Subject | Pregabalin | Small molecule | 150 mg | Oral |
| Subject | Pregabalin | Small molecule | 300 mg | Oral |
| Subject | Pregabalin | Small molecule | 600 mg | Oral |